Safety data sheet. GHS / OSHA HCS 2012 format, 16 sections. Issued by Epic Peptides Lab for the catalogue items listed in Section 1.

Epic Peptides Lab

Safety data sheet · capsules

Epic Peptides Lab · USA

Document number: PL-SDS-139
Revision: 1.0 · 2026-10-03

RAD-150

capsules

WARNING

1Identification

Product Identifier

RAD-150

Document Number

PL-SDS-139

Catalogue Items Covered

Id
8655
Name
RAD-150 (TLB-150) 5mg Capsules
Sku
PL-RAD150-5MG-CAP

Recommended Use

Laboratory research use by trained personnel.

Restrictions On Use

Not for human or veterinary use.

Supplier / Distributor

Epic Peptides Lab, USA

Telephone

+1 (787) 468-5291

info@epicpeptideslab.com

2Hazard(s) identification

Classification

Reproductive toxicity — Category 2 — H361
Specific target organ toxicity, repeated exposure — Category 2 — H373

Label Elements

Pictograms: GHS08
Signal: Warning
Hazard statements: H361 Suspected of damaging fertility or the unborn child.

H373 May cause damage to organs (liver) through prolonged or repeated exposure.
Precautionary statements: P201 Obtain special instructions before use.

P202 Do not handle until all safety precautions have been read and understood.

P260 Do not breathe dust, mist or spray.

P280 Wear protective gloves, protective clothing and eye protection.

P308+P313 IF exposed or concerned: Get medical advice/attention.

P314 Get medical advice/attention if you feel unwell.

P405 Store locked up.

P501 Dispose of contents and container to an approved waste disposal plant in accordance with local, state and federal regulations.

Signal Word

Warning

Other Hazards

No data available.

3Composition / information on ingredients

Description

Hard gelatin capsules containing the active substance blended with microcrystalline cellulose, packed in a sealed bottle.

Composition

Name
RAD-150
Full
RAD150 (TLB-150), benzoate ester of RAD140
Cas
1333223-66-7
Formula
C27H18ClN5O3
Conc
1.2% w/w of capsule contents (nominal)
Qty
5 mg per capsule
Hazards
- Reproductive toxicity — Category 2 — H361
- Specific target organ toxicity, repeated exposure — Category 2 — H373
Name
Microcrystalline cellulose
Full
Microcrystalline cellulose (capsule filler)
Cas
9004-34-6
Formula
(C6H10O5)n
Conc
balance of capsule contents
Name
Gelatin
Full
Gelatin (capsule shell)
Cas
9000-70-8
Conc
capsule shell

4First-aid measures

First Aid Measures

Inhalation: Move the person to fresh air and keep comfortable for breathing. If breathing is difficult or symptoms persist, call a POISON CENTER or doctor.
Skin: Take off contaminated clothing. Wash the skin with plenty of soap and water. If irritation or a rash develops, get medical advice.
Eyes: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do; continue rinsing. If eye irritation persists, get medical advice.
Ingestion: Rinse mouth. Do not induce vomiting. Call a POISON CENTER or doctor if you feel unwell.
General: If exposed or concerned, get medical advice. Show this safety data sheet to the doctor. Pregnant or nursing laboratory staff should avoid exposure.

Most Important Symptoms And Effects

No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

Likely Routes Of Exposure

Ingestion; inhalation of dust and skin/eye contact if capsules are opened.

5Fire-fighting measures

Fire Fighting Information: Combustible organic solid; capsule contents may form combustible dust if dispersed in bulk.

6Accidental release measures

Spill And Clean Up Procedures: Collect intact capsules. Dampen any spilled powder with water, wipe up with absorbent material and place in a sealed container for disposal.

7Handling and storage

Safe Handling: Do not open or crush capsules unless required for an experiment; if capsule contents are handled as a powder, avoid generating dust and weigh inside a ventilated enclosure. Wash hands after handling.
Safe Storage: Store at room temperature (15–25 °C) in the tightly closed original container, dry and protected from light.
Storage Temperature: 15–25 °C, dry, protected from light
Incompatible Materials: Strong oxidizing agents; strong acids/bases (ester hydrolysis)

8Exposure controls / personal protection

Occupational Exposure Limits: Microcrystalline cellulose: OSHA PEL 15 mg/m³ (total dust), 5 mg/m³ (respirable fraction); ACGIH TLV 10 mg/m³ (as cellulose).

No occupational exposure limits have been established for the active ingredient(s).
Exposure Controls And PPE: No data available.

9Physical and chemical properties

Physical State

Solid

Appearance

Hard gelatin capsules containing a white to off-white powder

Properties

Odor: Characteristic (parent RAD140, Cayman)
Ph: Not applicable (solid)
Melting: No data available
Boiling: 743.0 +/- 70.0 °C (predicted, ChemicalBook for TLB-150 benzoate)
Flash: Not applicable (non-flammable solid); combustible organic material
Vapour: Negligible (solid)
Density: No data available (bulk density of lyophilized cake is low)
Solubility: No data for RAD150; parent RAD140: DMF 30 mg/mL, DMSO 30 mg/mL, ethanol 2 mg/mL, ethanol:PBS (1:3) 0.25 mg/mL (Cayman)
Logp: No data available (lipophilic ester, expected higher than RAD140)
Decomp: No data available; peptides decompose above about 200 °C
Other: Benzoate ester of RAD140. Vendors give CAS 1208070-53-4, C27H20ClN5O3, MW 497.93 (TargetMol/ChemicalBook) - the group file's CAS 1333223-66-7 and formula C27H18ClN5O3 / 499.9 do not match these vendor…

10Stability and reactivity

Stability And Reactivity

Reactivity: Expected stable under recommended storage; parent RAD140: no dangerous reactions known (Cayman)
Incompatible: Strong oxidizing agents; strong acids/bases (ester hydrolysis)
Decomposition: Combustion: carbon oxides, nitrogen oxides, hydrogen chloride
Conditions To Avoid: Heat, moisture (ester hydrolysis), light

Conditions To Avoid

Heat, moisture (ester hydrolysis), light

Incompatible Materials

No data available.

11Toxicological information

Toxicological Information: Acute toxicity, oral
No data available

Acute toxicity, dermal
No data available

Acute toxicity, inhalation
No data available

Skin corrosion/irritation
No data for RAD150; parent RAD140: no irritant effect known (Cayman)

Serious eye damage/irritation
No data for RAD150; parent RAD140: no irritating effect known (Cayman)

Respiratory or skin sensitisation
No data; parent RAD140: no sensitizing effects known (Cayman)

Germ cell mutagenicity
No data available

Carcinogenicity
Not listed by IARC, NTP, OSHA

Reproductive toxicity
No supplier data. Class remark: SARMs are androgen receptor agonists; several SARM SDSs carry H361 'Suspected of damaging fertility or the unborn child'; RAD140 suppresses the HPG axis and testosterone in animals and humans - a careful author should consider H361

STOT, single exposure
No data available

STOT, repeated exposure
No data available. Remark: RAD140 produced drug-induced liver injury in a phase 1 breast-cancer trial and in case reports; FDA has warned that SARMs are associated with liver toxicity, heart attack and stroke risk

Aspiration hazard
No data available
Routes Of Exposure: Ingestion; inhalation of dust and skin/eye contact if capsules are opened.
Symptoms: No specific symptoms are known. Pharmacologically active material: systemic effects consistent with its mechanism of action are possible after accidental injection, ingestion or absorption.

12Ecological information

Ecological Information: No data available (ChemicalBook for RAD140). Parent RAD140: Cayman self-assesses water hazard class 1 (slightly hazardous for water). Lipophilic aromatic - potential for bioaccumulation; keep out of drains.

13Disposal considerations

Disposal Guidance: No data available.

14Transport information

Transport Classification

Note: Not regulated as a dangerous good for transport by road (DOT 49 CFR), air (IATA/ICAO) or sea (IMDG). Not a marine pollutant. Ship refrigerated or frozen as required by Section 7; the coolant (dry ice, UN 1845) is regulated when used.

15Regulatory information

Regulatory Information

Tsca: Not listed
Carcinogen Listings: Not listed
Dea: Not currently a US controlled substance (SARMs are not scheduled under the CSA; the proposed SARMs Control Act has not been enacted as of research date - verify); FDA considers SARMs unapproved drugs and has issued warning letters for their sale as supplements
Other: WADA remark: prohibited at all times under S1.2 (other anabolic agents - SARMs, e.g. RAD140). DSHEA: not a lawful dietary ingredient.

Carcinogen Listings

No data available.

16Other information

Revision: October 3, 2026
Sources Consulted: Cayman Chemical

ChemicalBook

TargetMol via CymitQuimica

Spectrum Chemical

Sigachi Industries

Parchem

Fisher Scientific / Acros Organics

Electron Microscopy Sciences
Confidence: low
Additional Information: Selective androgen receptor modulator (SARM). No supplier SDS assigns a reproductive classification, but SARMs act on the androgen receptor, suppress gonadotropins and spermatogenesis in animal and human studies and are prohibited at all times under WADA class S1.2. PrymaLab therefore self-classifies the substance as Reproductive toxicity Category 2 (H361) by expert judgement.

Identifier discrepancy between vendors (CAS 1208070-53-4 / C27H20ClN5O3 / 497.9 vs CAS 1333223-66-7 / C27H18ClN5O3 / 499.9); the vendor record for the lot governs.

Back to SDS list